tiprankstipranks
Advertisement
Advertisement
Hoth Therapeutics announces $2M registered direct offering
PremiumThe FlyHoth Therapeutics announces $2M registered direct offering
1M ago
Hoth Therapeutics reports results from ongoing HT-001 program
Premium
The Fly
Hoth Therapeutics reports results from ongoing HT-001 program
1M ago
Hoth Therapeutics announces issuance of Chinese patent
Premium
The Fly
Hoth Therapeutics announces issuance of Chinese patent
1M ago
Hoth Therapeutics’ HT-VA GDNF shows superior efficacy in obesity
PremiumThe FlyHoth Therapeutics’ HT-VA GDNF shows superior efficacy in obesity
3M ago
Hoth Therapeutics confirms it holds no cryptocurrency assets
Premium
The Fly
Hoth Therapeutics confirms it holds no cryptocurrency assets
3M ago
Hoth Therapeutics’ HT-001 shows 100% response in EFGR-treated cancer patients
Premium
The Fly
Hoth Therapeutics’ HT-001 shows 100% response in EFGR-treated cancer patients
3M ago
Hoth Therapeutics files $50M mixed securities shelf
PremiumThe FlyHoth Therapeutics files $50M mixed securities shelf
6M ago
Hoth Therapeutics’ HT-KIT granted FDA Orphan Drug Designation
Premium
The Fly
Hoth Therapeutics’ HT-KIT granted FDA Orphan Drug Designation
6M ago
Hoth Therapeutics Prepares Presentation on October 17, 2025
Premium
Company Announcements
Hoth Therapeutics Prepares Presentation on October 17, 2025
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100